N-Chlorotaurine Inacitvates Shiga Toxin 29. Maekawa LE, Valera MC, Oliveira LD, Carvalho CA, Koga-Ito CY, et al. (2011) In vitro evaluation of the action of irrigating solutions associated with intracanal medications on Escherichia coli and its endotoxin in root canals. J Appl Oral Sci 19: 106–112. 30. Zgliczynski JM, Stelmaszynska T, Domanski J, Ostrowski W (1971) Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase. Biochim Biophys Acta 235: 419–424. 31. Arnitz R, Sarg B, Ott HW, Neher A, Lindner H, et al. (2006) Protein sites of attack of N-chlorotaurine in Escherichia coli. Proteomics 6: 865–869. 32. Olszowski S, Olszowska E, Stelmaszynska T, Krawczyk A, Marcinkiewicz J, et al. (1996) Oxidative modification of ovalbumin. Acta Biochim Pol 43: 661–672. 33. Gottardi W, Hagleitner M, Nagl M (2005) N,N-Dichlorotaurine: chemical and bactericidal properties. Arch Pharm Pharm Med Chem 338: 473–483. 34. Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77: 598– 625. 35. Winterbourn CC, Hampton MB, Livesey JH, Kettle AJ (2006) Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem 281: 39860–39869. 36. Witko Sarsat V, Delacourt C, Rabier D, Bardet J, Nguyen AT, et al. (1995) Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med 152: 1910–1916. 37. Orth-Ho¨ller D, Riedl M, Wu¨ rzner R (2011) Inhibition of terminal complement activation in severe Shiga toxin-associated HUS - perfect example for a fast track from bench to bedside. EMBO Mol Med 3: 617–619. 38. Zhang W, Bielaszewska M, Pulz M, Becker K, Friedrich AW, et al. (2008) New immuno-PCR assay for detection of low concentrations of shiga toxin 2 and its variants. J Clin Microbiol 46: 1292–1297. 39. Gottardi W, Pfleiderer J (2005) Redox-iodometry: a new potentiometric method. Anal Bioanal Chem 382: 1328–1338. 40. Satchell SC, Anderson KL, Mathieson PW (2004) Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol 15: 566–574. 41. Satchell SC, Tasman CH, Singh A, Ni L, Geelen J, et al. (2006) Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 69: 1633–1640. 42. Schagger H, von JG (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368–379. 43. Sobieszek A, Matusovsky OS, Permyakova TV, Sarg B, Lindner H, et al. (2006) Phosphorylation of myorod (catchin) by kinases tightly associated to molluscan and vertebrate smooth muscle myosins. Arch Biochem Biophys 454: 197–205. PLOS ONE | www.plosone.org 13 November 2012 | Volume 7 | Issue 11 | e47105